NCT06702033View on ClinicalTrials.gov

The Minimalist Trial-2

PHASE2RecruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

April 30, 2030

Study Completion Date

July 15, 2033

Conditions
HPV-Related Oropharynx Squamous Cell Carcinoma
Interventions
RADIATION

Radiation therapy

IMRT or IMPT

DRUG

Cisplatin

Dose of 100 mg/m\^2 IVPB over 60 minutes

PROCEDURE

Surgery

Standard of care

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

The Joseph Sanchez Foundation

UNKNOWN

lead

Washington University School of Medicine

OTHER